Publications by authors named "Florin V Chirila"

A definitive diagnosis of Alzheimer's disease (AD), even in the presence of co-morbid neuropathology (occurring in > 50% of AD cases), is a significant unmet medical need that has obstructed the discovery of effective AD therapeutics. An AD-biomarker, the Morphometric Imaging (MI) assay on cultured skin fibroblasts, was used in a double-blind, allcomers (ages 55-90) trial of 3 patient cohorts: AD dementia patients, N = 25, all autopsy confirmed, non-AD dementia patients, N = 21-all autopsy or genetically confirmed; and non-demented control (AHC) patients N = 27. Fibroblasts cells isolated from 3-mm skin punch biopsies were cultured on a 3-D Matrigel matrix with movement dynamics quantified by image analysis.

View Article and Find Full Text PDF

Bryostatin 1, a potent activator of protein kinase C epsilon (PKCɛ), has been shown to reverse synaptic loss and facilitate synaptic maturation in animal models of Alzheimer's disease (AD), Fragile X, stroke, and other neurological disorders. In a single-dose (25 μg/m2) randomized double-blind Phase IIa clinical trial, bryostatin levels reached a maximum at 1-2 h after the start of infusion. In close parallel with peak blood levels of bryostatin, an increase of PBMC PKCɛ was measured (p = 0.

View Article and Find Full Text PDF

The inaccuracy of the diagnosis for Alzheimer's disease (AD) has made its therapeutic intervention difficult, particularly early enough to prevent significant neurodegeneration and cognitive dysfunction. Here, we describe a novel, highly accurate peripheral diagnostic for AD patients based on quantitatively measured aggregation rate of human skin fibroblasts. The elevated aggregation rate with increasing cell density in AD cases is the basis of this new biomarker.

View Article and Find Full Text PDF

Drugs to treat Alzheimer's disease (AD) have been unsuccessful in preventing its devastating cognitive deficits and progressive neurodegeneration. The lack of a definitive diagnostic for AD has been a major obstacle to AD drug discovery. Here, we describe a novel, highly accurate peripheral diagnostic for AD patients based on quantitatively measured complexity of skin-sampled fibroblast networks.

View Article and Find Full Text PDF
Article Synopsis
  • The medial superior olive (MSO) neurons are highly sensitive to tiny differences in timing between sounds heard by each ear, a capability influenced by their electrical properties, input timing, and dendrite structure.
  • The study found that MSO neurons start to show this sensitivity early in auditory development around postnatal day 10 (P10), with important changes occurring by P14 to resemble adult-like responses.
  • As these neurons mature, the complexity of their dendritic branching decreases, and the balance of excitatory and inhibitory signals adjusts, which may allow for fine-tuning of auditory processing even before hearing is fully developed.
View Article and Find Full Text PDF

Spatiotemporal networks are studied in a photosensitive Belousov-Zhabotinsky medium that allows both local and nonlocal transmission of excitation. Local transmission occurs via propagating excitation waves, while nonlocal transmission takes place by nondiffusive jumps to destination sites linked to excited sites in the medium. Static, dynamic, and domain link networks are experimentally and computationally characterized.

View Article and Find Full Text PDF